Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.60 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.57 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.53 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30610463 | 1.00 | LOXL2 (0.60) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL30939506 | 0.89 | BCHE (0.56) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL3193911 | 0.89 | BCHE (0.56) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL7169246 | 0.87 | LOXL2 (0.69) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL31059889 | 0.87 | LOXL2 (0.69) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL369110 | 0.87 | CTSV (0.60) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL30382957 | 0.87 | CTSV (0.60) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| Hydrochloric Acid SCHEMBL11231439 | 0.87 | BCHE (0.55) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL10513013 | 0.85 | CTSV (0.63) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 | |
| SCHEMBL3702698 | 0.85 | CTSV (0.63) | LOXL2MTNR1AMTNR1BHRH3CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114014264-A | Hydrogen storage material and preparation method thereof | 株洲铂陆新能源科技有限公司 | 2022-02-08 | — | — | CN | claimed |
| CN-106995400-B | A kind of compound and its salt and its synthetic method | 湘潭大学 | 2019-08-06 | — | — | CN | claimed |
| WO-2017160361-A1 | POLYISOCYANURATE CATALYSTS FOR METAL PANELS AND SPRAY FOAMS | HUNTSMAN PETROCHEMICAL LLC (US) | 2017-09-21 | — | — | WO | claimed |
| CN-106985688-A | Battery status monitoring system and method for electric automobile | 浙江农业商贸职业学院 | 2017-07-28 | — | — | CN | claimed |
| CN-106945548-A | Charging system for electric automobile and method based on wireless charging | 浙江工业职业技术学院 | 2017-07-14 | — | — | CN | claimed |
| CN-106926724-A | Electric automobile charging station and charging electric vehicle method based on regenerative resource | 浙江农业商贸职业学院 | 2017-07-07 | — | — | CN | claimed |
| CN-104555914-B | Liquid hydrogen storage system | 江苏氢阳能源有限公司 | 2017-06-13 | — | — | CN | claimed |
| WO-2026106815-A1 | Z-INDUCING CHIMERA COMPOSITION | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-118420511-A | Synthesis method of 2-alkyl indole | 南京工业大学 | 2024-08-02 | — | — | CN | disclosed |
| US-12043674-B2 | Synthetic cyclic peptides and methods of preparation and use thereof | AUBURN UNIVERSITY (US) | 2024-07-23 | — | — | US | disclosed |
| WO-2024059951-A1 | INHIBITORS OF THE ANDROGEN RECEPTOR DNA-BINDING DOMAIN | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-03-28 | — | — | WO | disclosed |
| CN-113332933-B | On-vehicle organic liquid hydride dehydrogenation reactor | 南京工业大学 | 2023-11-21 | — | — | CN | disclosed |
| WO-2023116779-A1 | DIALKYNE COMPOUND AND USE THEREOF | 上海艾力斯医药科技股份有限公司 | 2023-06-29 | — | — | WO | disclosed |
| US-4251446-A | COLOR PRECURSORS | STERLING DRUG INC. (US) | 1981-02-17 | — | — | US | disclosed |
| US-4243807-A | CHEMICAL INTERMEDIATES FOR HYPOTENSIVE AGENTS | BOEHRINGER MANNHEIM GMBH (DE) | 1981-01-06 | — | — | US | disclosed |
| US-4189171-A | PRESSURE SENSITIVE, THERMAL AND HECTOGRAPHIC SYSTEMS | STERLING DRUG INC. (US) | 1980-02-19 | — | — | US | disclosed |
| US-4104402-A | BRONCHODILATORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1978-08-01 | — | — | US | disclosed |
| US-4075224-A | 3,5-Bis (indolyl)-5-(indolyl)-2(5H)-furanones | STERLING DRUG INC. (US) | 1978-02-21 | — | — | US | disclosed |
| US-4035512-A | Aminotetralols | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1977-07-12 | — | — | US | disclosed |
| US-4010202-A | TREATMENT OF ASTHMA AND ARRHYTHMIA | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1977-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043674-B2 | Synthetic cyclic peptides and methods of preparation and use thereof | VIP, PTMS, IAPP | LOXL2 4704/4885MTNR1A 4020/4885MTNR1B 3363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.